Defence Therapeutics Inc. (CSE:DTC)
Canada
· Delayed Price · Currency is CAD 0.620
-0.020 (-3.13%)
At close: Mar 6, 2026
Defence Therapeutics Market Cap
Defence Therapeutics has a market cap or net worth of CAD 35.57 million as of March 6, 2026. Its market cap has decreased by -39.82% in one year.
Market Cap
35.57M
Enterprise Value
36.11M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.62
Market Cap Chart
Since May 7, 2021, Defence Therapeutics's market cap has decreased from 89.08M to 35.57M, a decrease of -60.07%. That is a compound annual growth rate of -17.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 35.57M | -13.89% |
| Dec 31, 2025 | 41.31M | 31.21% |
| Dec 31, 2024 | 31.48M | -69.62% |
| Dec 29, 2023 | 103.61M | 5.29% |
| Dec 30, 2022 | 98.41M | -49.44% |
| Dec 31, 2021 | 194.63M | 118.48% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Microbix Biosystems | 33.25M |
| Resverlogix | 37.89M |
| Devonian Health Group | 38.03M |
| BriaCell Therapeutics | 39.88M |
| Telescope Innovations | 28.28M |
| MedMira | 45.33M |
| Thiogenesis Therapeutics | 26.95M |
| Sernova Biotherapeutics | 47.47M |